Pediatrician workforce policy statement

Pediatrics
|July 31, 2013
PubMed

Insights

The American Academy of Pediatrics (AAP) identifies a shortage in pediatric subspecialists and surgical specialists. Future needs for primary care pediatricians are increasing due to complex health needs and healthcare reforms.

Area of Science:

  • Pediatric Health Care Policy
  • Physician Workforce Analysis
  • Healthcare Access and Equity

Background:

  • Trends impacting pediatric healthcare delivery and the pediatrician workforce are reviewed.
  • Changes in the pediatric patient population and the nature of pediatric practice are analyzed.
  • The effects of these shifts on pediatrician demand and patient care are discussed.

Purpose of the Study:

  • To review trends affecting the pediatrician workforce and pediatric healthcare.
  • To discuss the impact of these trends on pediatricians and demand for care.
  • To summarize policy recommendations for addressing pediatrician workforce issues.

Main Methods:

  • Policy statement review.
  • Analysis of workforce trends and patient population changes.
  • Synthesis of data on pediatric subspecialty and primary care needs.

Main Results:

  • A shortage of pediatric medical subspecialists and surgical specialists exists.
  • Current primary care pediatrician distribution is inadequate for rural/underserved areas.
  • Increased demand for primary care pediatricians is projected due to chronic conditions, work hour changes, and health reform.

Conclusions:

  • The American Academy of Pediatrics (AAP) concludes there are shortages in pediatric subspecialty and surgical care.
  • Inadequate distribution of primary care pediatricians affects underserved populations.
  • Future healthcare reforms necessitate more primary care pediatricians for comprehensive child care.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
International Nursing Organizations II01:28

International Nursing Organizations II

The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...